A comparative Clinical study on the effect of Arjuna-RasonÄ?di yoga & Navaka guggulu On Medodushti

Phase 2

Not yet recruiting

Conditions: Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Registration Number: CTRI/2021/12/038393

Lead Sponsor: ational Institute Of Ayurveda deemed to be universityjaipur

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1 Willing to give written informed consent and willing to comply with trial protocol.

2 Subjects in the age group of 18â??70 years of both genders.

3 As per ATP III guidelines; baseline LDL ranging 160- 189mg/dl, TC >=200 mg/dL, TG ranging 150-199 mg/dL.

4 Ability to understand the risks or benefits of the protocol.

5 Subject should be available for duration of study period.

Exclusion Criteria

1 Participants with chronic diseases requiring continuous use of vasoactive drugs, diuretics, lipid-lowering or anti-diabetic drugs.

2 Subjects having history of diabetes (Type I or Type II) except other than the subject having the prediabetes condition with the random blood glucose 140-199 mg/dl.

3 Subjects suffered from intractable obesity, had defined weight limits or had experienced any recent, unexplained weight loss or gain.

4 Subjects having history of serious cardiovascular diseases such MI.

5 Subjects having abnormal liver (ALT or AST) 2 times the upper limit of normal;

6 Subjects having abnormal findings on complete blood count.

7 Subjects having history of high alcohol intake (2 standard drinks per day).

8 Subjects having history of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

9 Any other condition that, in the opinion of the investigator, would adversely affect the subjectâ??s ability to complete the study or its measures.

10 Subjects participated in any other clinical trials within thirty (30) days prior to screening.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in the levels at Day 60 from the baseline in: <br/ ><br>1.Lipid Profile (Total cholesterol, HDL, LDL, VLDL & TGL) <br/ ><br>Timepoint: Change in the levels at Day 60 from the baseline in: <br/ ><br>1.Lipid Profile (Total cholesterol, HDL, LDL, VLDL & TGL) <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
Change in the levels at Day 60 from the baseline in: <br/ ><br>1 Total Cholesterol/ HDL ratio <br/ ><br>2 Changes in Blood Pressure ((BP) from baseline till 60th Day visit <br/ ><br>Timepoint: Change in the levels at Day 60 from the baseline in: <br/ ><br>1 Total Cholesterol/ HDL ratio <br/ ><br>2 Changes in Blood Pressure ((BP) from baseline till 60th Day visit <br/ ><br>